Dr. Abdelrahman Hammad

• Chief Executive Officer (CEO), Iwan Psychiatric Hospital.
• Former director of the addiction unit, Abbasiya Hospital.
• Recipient of CBT training certificate for Anxiety and Depression Disorders from the Beck Institute
• Recipient of DBT training certificate from the Linehan Institute.
• Holds a Dialectical Behavioral Therapy (DBT) training certificate from Masar Center.
• Received Motivational interviewing training from the Center for Motivation and Change – UK
• Has taught courses leading to a diploma in drug control at the National Center for Social and Criminal Research, and participated in research and training activities at the National Council for Combating and Treating Addiction.
• Participated in writing the national document to raise awareness of the dangers of drug abuse and addiction for pre-university education levels, as one of the experts on the Addiction Control and Treatment Fund and the Curriculum Development Center at the Ministry of Education.
• Participated in the supervision and preparation of various awareness programs on the drug abuse and addiction problem.
• Participates in giving awareness lectures for students of Egyptian universities and institutes in various governorates.
• Participates in the various media to raise awareness of the drug abuse and addiction problem.
• A former lecturer in the prevention programs of the Addiction Control and Treatment Fund, and former general supervisor of the hotline at the Abbasiya Psychiatric Hospital.
• Certified trainer in the UN program for drug control and treatment.
• Hospital management specialist.

Participated in the preparation and publication of three research papers that were published in international conferences:

• National drug facts week campaign in Egypt in collaboration with NIDA
• A probable stimulant use disorder and withdrawal syndrome linked to Modafinil: A case report – European Psychiatric Association – EPA, in its annual international conference held in Poland.
• From a potential treatment to probable harm: A case series of Pregabalin withdrawal syndrome – American Psychiatric Association – APA